Pheochromocytoma and Paraganglioma: Incidence and Comparative Analysis Between Familial and Sporadic Cases in a Portuguese Single Center
DOI:
https://doi.org/10.20344/amp.24192Keywords:
Neuroendocrine Tumors/epidemiology, Paraganglioma/diagnosis, Paraganglioma/epidemiology, Pheochromocytoma/diagnosis, Pheochromocytoma/epidemiologyAbstract
Pheochromocytomas and paragangliomas are rare neuroendocrine tumors, with an estimated incidence rate of two to eight cases per million people, and one of the highest heritability rates among neoplasms, with a genetic cause identified in approximately 40% of cases. This study analyzed cases diagnosed within the referral area of Unidade Local de Saúde de Braga between 2004 and 2024, aiming to estimate incidence, characterize the population, and compare sporadic and familial pheochromocytomas and paragangliomas. A total of 85 patients were identified, corresponding to 87 cases, with an average annual incidence of 5.3 cases per million between 2012 and 2024 and a rising trend over the study period. Genetic testing was performed in 61 patients, revealing 43 sporadic and 20 familial cases. The age at diagnosis was significantly lower in familial cases (43.4 ± 12.7 years; p < 0.001). Metastatic disease occurred only in patients with familial pheochromocytomas and paragangliomas, four and six years after diagnosis, while recurrences were observed exclusively in sporadic cases, with a median of seven years after complete remission. These findings highlight the importance of genetic testing and long-term follow-up in patients with pheochromocytoma and paraganglioma, given the risk of metastasis and recurrence even several years after the initial diagnosis.
Downloads
References
Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, Mitjavila-Casanovas M, Robledo M, Tena I, et al. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021;23:1995-2019. DOI: https://doi.org/10.1007/s12094-021-02622-9
Geroula A, Deutschbein T, Langton K, Masjkur J, Pamporaki C, Peitzsch M, et al. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. Eur J Endocrinol. 2019;181:409-20. DOI: https://doi.org/10.1530/EJE-19-0159
Aggarwal S, Prete A, Chortis V, Asia M, Sutcliffe RP, Arlt W, et al. Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary center experience. J Clin Endocrinol Metab. 2023;109:e389-96. DOI: https://doi.org/10.1210/clinem/dgad401
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, et al. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev. 2022;43:199-239. DOI: https://doi.org/10.1210/endrev/bnab019
Jhawar S, Arakawa Y, Kumar S, Varghese D, Kim YS, Roper N, et al. New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications. Cancers. 2022;14. DOI: https://doi.org/10.3390/cancers14030594
Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915-42. DOI: https://doi.org/10.1210/jc.2014-1498
Lider Burciulescu SM, Randon C, Duprez F, Huvenne W, Creytens D, Claes KB, et al. Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma. Endocr Oncol. 2023;3:e220040. DOI: https://doi.org/10.1530/EO-22-0040
Chung R, O’Shea A, Sweeney AT, Mercaldo ND, McDermott S, Blake MA. Hereditary and sporadic pheochromocytoma: comparison of imaging, clinical, and laboratory features. AJR Am J Roentgenol. 2022;219:97-109. DOI: https://doi.org/10.2214/AJR.21.26918
Fundação Francisco Manuel dos Santos. População residente por sexo e grupo etário. PORDATA. 2025. [cited 2025 Feb 27]. Available from: https://www.pordata.pt/pt/estatisticas/populacao/populacao-residente/populacao-residente-por-sexo-e-grupo-etario.
Berends AM, Buitenwerf E, de Krijger RR, Veeger N, van der Horst-Schrivers AN, Links TP, et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur J Intern Med. 2018;51:68-73. DOI: https://doi.org/10.1016/j.ejim.2018.01.015
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
